Inhibiting tumour growth by targeting EphA3 and disrupting tumour stromal and vascular microenvironment

  • Janes, Peter (Primary Chief Investigator (PCI))
  • Elefanty, Andrew (Chief Investigator (CI))
  • Vail, Mary (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/13 → 31/12/15

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$622,869.99